Greenwich LifeSciences, Inc.
NASDAQ:GLSI · NASDAQ Capital Market
-$0.74 today
Vol 0.09M · Avg 0.14M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+166.89%
Period High
$33.57
Period Low
$7.85
Latest
$23.38
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Immix Biopharma, Inc.
NASDAQ:IMMX
$507.57M
Opus Genetics, Inc.
NASDAQ:IRD
$334.39M
Surrozen, Inc.
NASDAQ:SRZN
$170.45M
TuHURA Biosciences, Inc.
NASDAQ:HURA
$149.65M
Agenus Inc.
NASDAQ:AGEN
$122.43M
Cognition Therapeutics, Inc.
NASDAQ:CGTX
$102.65M
Oncolytics Biotech Inc.
NASDAQ:ONCY
$95.09M
Seer, Inc.
NASDAQ:SEER
$94.57M
Tevogen Bio Holdings Inc.
TVGN
$41.94M
Atossa Therapeutics, Inc.
ATOS
$16.88M
What is the latest GLSI filing?
The latest filing shown is 10-Q dated Jun 4, 2026.
How many recent filings does GLSI have?
Intrinsic Alpha currently shows 20 recent filings for GLSI.
Explore More
Continue the stock analysis
Jump to another research area for this company.